Kerna Labs

Foundation models for better genetic medicines

Kerna is building computational models that design therapeutically optimized mRNA sequences. Kerna's founding team includes Melissa J. Moore, the former Chief Scientific Officer of Moderna.

Under the radar for now - more info soon.

2024

XEIA invests

2025

$5M Seed led by Susa

$5M Seed led by Susa

https://kernalabs.ai/

The latest from 

Kerna Labs

Podcast
Jan 15, 2025

AI designed mRNA therapies: a Universal Toolkit for Genetic Medicine

How Kerna is building foundation AI models to unlock the full potential of mRNA
News
Jan 10, 2025

Kerna Labs raises Seed from Susa & Google's AI fund

Moderna's former CSO has a new startup using AI to improve mRNA therapies

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
Human 3 manifestoNews & contentPortfolioPodcastJobs
X-disciplinary Exploration, Investment & Acceleration
‍
© 2025 XEIA Venture Partners, LLC